| 1 |
35447344 | The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase. | 2022 Jul 1 |
1 |
| 2 |
29279995 | Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons. | 2018 Nov |
1 |
| 3 |
30341696 | Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases. | 2018 Nov |
1 |
| 4 |
28577058 | Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline. | 2017 Sep |
4 |
| 5 |
28682929 | Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease. | 2017 Sep/Oct |
1 |
| 6 |
25196265 | Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease. | 2014 Oct |
2 |
| 7 |
22968599 | Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. | 2013 Mar |
11 |
| 8 |
23739004 | Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. | 2013 Jun |
2 |
| 9 |
22065207 | Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. | 2012 Apr |
3 |
| 10 |
19733607 | Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. | 2009 Nov 13 |
1 |
| 11 |
19763773 | Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. | 2009 Nov |
1 |
| 12 |
17447417 | Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection. | 2006 |
1 |
| 13 |
16366596 | Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis. | 2005 Dec 29 |
2 |
| 14 |
15027867 | Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. | 2004 Mar 25 |
2 |
| 15 |
12504917 | Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. | 2002 Dec |
1 |